Desde la primera línea, buscando el mejor abordaje del paciente con Cáncer gástrico metastásico

25 / 56

AIO-STO-0415: RAMIRIS trial
25
• Gastric/GEJ adenocarcinoma
• PD during or within 6m of the last dose
of 1L platinum and fluoropyrimidine
doublet with or without anthracycline
or docetaxel
• PS0-1
N=111
FOLFIRI +
Ramucirumab
28-day cycle
Paclitaxel +
Ramucirumab
28-day cycle
Primary endpoint
• OS at 6 months
Secondary endpoints
• PFS
• ORR
• DCR
• Safety
• QOL
PI: Sylvie Lorenzen, MD
Trial contact person: Salah-Eddin Al-Batran, Prof